Tetralogic Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Tetralogic Pharmaceuticals's estimated annual revenue is currently $1.9M per year.(i)
  • Tetralogic Pharmaceuticals's estimated revenue per employee is $155,000

Employee Data

  • Tetralogic Pharmaceuticals has 12 Employees.(i)
  • Tetralogic Pharmaceuticals grew their employee count by 0% last year.

Tetralogic Pharmaceuticals's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Tetralogic Pharmaceuticals?

TetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious diseases. We currently have two clinical-stage product candidates in development: birinapant and suberohydroxamic acid (4-methoxycarbonyl) phenyl ester (SHAPE).

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.4M12-87%N/A
#2
$1.5M12N/AN/A
#3
$2M130%N/A
#4
$1.8M1427%N/A
#5
$2M15-29%N/A